Loading...
•
Dec 31, 2021
Natera Q4 2021 Earnings Report
Natera reported a 53.9% increase in total revenues driven by product revenues growth.
Key Takeaways
Natera's Q4 2021 total revenues increased by 53.9% compared to Q4 2020, driven by product revenue growth. The company processed 438,800 tests in the fourth quarter of 2021, including 424,200 tests accessioned in its laboratory.
Total revenues were $173.0 million, a 53.9% increase compared to Q4 2020.
Product revenues were $160.9 million, a 51.1% increase compared to Q4 2020.
Approximately 438,800 tests were processed in Q4 2021.
Net loss for the fourth quarter of 2021 was $140.6 million, or ($1.48) per diluted share.
Forward Guidance
Natera anticipates 2022 total revenue of $770 million to $790 million; 2022 gross margin to be approximately 46% to 48% of revenues; selling, general and administrative costs to be approximately $560 million to $590 million; research and development costs to be $340 million to $360 million, and net cash consumption to be $370 million to $400 million.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...